Monthly Archives: April 2019

Veterans with gastroesophageal reflux disease needed for study

Posted in News | Comments Off on Veterans with gastroesophageal reflux disease needed for study

Employee Health and Fitness Day celebration is tomorrow

Posted in News | Comments Off on Employee Health and Fitness Day celebration is tomorrow

VUMC named among “100 great hospitals in America”

Becker’s Hospital Review has once again named Vanderbilt University Medical Center as one of the “100 great hospitals in America.” Continue reading

Posted in News | Comments Off on VUMC named among “100 great hospitals in America”

“Journey to a Healthy Life” presentation is May 2 in Light Hall

Posted in News | Comments Off on “Journey to a Healthy Life” presentation is May 2 in Light Hall

Study merges big data and zebrafish biology to reveal mechanisms of human disease

In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease. Continue reading

Posted in News | Comments Off on Study merges big data and zebrafish biology to reveal mechanisms of human disease

Asian nations in early tobacco epidemic: study

Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases. Continue reading

Posted in News | Comments Off on Asian nations in early tobacco epidemic: study

Limited Submission Opportunity: 2019 Mallinckrodt Grant Program

Posted in News | Comments Off on Limited Submission Opportunity: 2019 Mallinckrodt Grant Program

Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration

Posted in News | Comments Off on Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

Polycystic liver disease is the most common extra-renal manifestation of autosomal dominant polycystic kidney disease (ADPKD). There is need for robust long-term evidence for the volume-reducing effect of somatostatin analogues. We made use of data fro… Continue reading

Posted in News | Comments Off on Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome

Little is known about the link between pathophysiologic factors and symptoms of irritable bowel syndrome (IBS), or whether these factors have cumulative effects on patient-reported outcomes (PROs). We investigated whether pathophysiologic alterations a… Continue reading

Posted in News | Comments Off on Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome